Long-term support with an ambulatory percutaneous paracorporeal artificial lung

The Journal of Heart and Lung Transplantation, 05/25/2012

Authors successfully established long–term ambulatory PAL for up to 24 days using the patented DLC through a single–site percutaneous venous cannulation. Critical bleeding/thrombosis formation and gas exchanger durability remain two major challenges for long–term–ambulatory PAL.

Print Article Summary Cat 2 CME Report